NCT00379418View on ClinicalTrials.gov

Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Coronary Artery Disease
Interventions
DRUG

Abciximab

Trial Locations (2)

30033

Atlanta VA Medical Center, Atlanta

30322

Emory University Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT00379418 - Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients | Biotech Hunter | Biotech Hunter